Ropes & Gray has advised leading global private markets firm, Partners Group, acting on behalf of its clients, on its investment in GHO Capital Partners’ portfolio company, Sterling Pharma Solutions (“Sterling”), a global Contract Development and Manufacturing Organisation (“CDMO”).
Sterling provides a full range of CDMO services across the lifecycle of new, high-value active pharmaceutical ingredients (“APIs”) and is an industry leader in the early-stage development of antibody drug conjugates (“ADCs”), a fast-growing class of cancer treatments. It benefits from a diversified blue-chip customer base and is a supply chain partner for the majority of the largest pharmaceutical companies.
Partners Group acquires a significant minority stake, bringing a wealth of international healthcare expertise to the shareholder group and helping drive future value creation.
The new investment will support Sterling as it accelerates its growth plans through the expansion of production capacity across Europe and the US. The funding also enables it to pursue further strategic acquisitions to further expand its capabilities and continue to advance its strong commitment to ESG initiatives.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
The advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
